Comparative evaluation of 0.5% Attukal Kizhangu (Drynaria fortunei) herbal mouthwash and 0.2% chlorhexidine in the management of periodontal diseases: A randomized controlled clinical trial
Journal of Indian Society of Periodontology · 2026-07 · 30 (3) · 392-400
DOI: 10.4103/jisp.jisp_80_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Indian Society of Periodontology, online erschienen am 29.10.2026. Verfasst von Sakshi Gupta und 3 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Periodontal diseases are chronic inflammatory conditions caused by microbial dental plaque. Although 0.2% chlorhexidine (CHX) is the gold standard adjunctive mouthwash for plaque control, its long-term use is associated with adverse effects, including tooth staining, altered taste sensation, and mucosal irritation. Attukal Kizhangu (Drynaria fortunei), a medicinal fern with antimicrobial, anti-inflammatory, antioxidant, and regenerative properties, has emerged as a potential herbal alternative.
Aim
To formulate and characterize a 0.5% Attukal Kizhangu herbal mouthwash and evaluate its antimicrobial efficacy and clinical effectiveness compared with 0.2% CHX and normal saline. Materials and Methods: A randomized, parallel-arm, examiner-blinded clinical trial was conducted among 72 participants with gingivitis or periodontitis. Participants received normal saline, 0.2% CHX, or 0.5% Attukal Kizhangu mouthwash. The formulation was characterized by high-resolution mass spectrometry, pH, surface tension, stability, and antimicrobial susceptibility testing. Following scaling and root planing, participants used the assigned mouthwash twice daily for 90 days. Clinical outcomes were assessed using the oral hygiene index-simplified (OHI-S), plaque index (PI), gingival index (GI), and gingival bleeding score (GBS).
Results
Both the Attukal Kizhangu and CHX groups showed significant reductions in OHI-S, PI, GI, and GBS scores after 3 months ( P < 0.001), with no significant intergroup difference ( P = 0.08). Approximately 75% of participants achieved complete resolution of gingival bleeding. The herbal mouthwash also demonstrated satisfactory physicochemical stability and significant antimicrobial activity.
Conclusion
The 0.5% Attukal Kizhangu herbal mouthwash demonstrated efficacy comparable to 0.2% CHX and may serve as a promising herbal adjunct in periodontal therapy. Larger multicenter trials with longer follow-up are required to confirm its long-term safety and effectiveness.
Zitieren
APA
Gupta, S., Mittal, N., Baranwal, H. C., & Dubey, P. (2026). Comparative evaluation of 0.5% Attukal Kizhangu (Drynaria fortunei) herbal mouthwash and 0.2% chlorhexidine in the management of periodontal diseases: A randomized controlled clinical trial. Journal of Indian Society of Periodontology, 30(3), 392-400. https://doi.org/10.4103/jisp.jisp_80_25
Vancouver
Gupta S, Mittal N, Baranwal HC, Dubey P. Comparative evaluation of 0.5% Attukal Kizhangu (Drynaria fortunei) herbal mouthwash and 0.2% chlorhexidine in the management of periodontal diseases: A randomized controlled clinical trial. Journal of Indian Society of Periodontology. 2026;30(3):392-400. doi:10.4103/jisp.jisp_80_25
BibTeX
@article{Gupta2026,
author = {Gupta, Sakshi and Mittal, Neelam and Baranwal, Harakh Chand and Dubey, Pragati},
title = {Comparative evaluation of 0.5% Attukal Kizhangu (Drynaria fortunei) herbal mouthwash and 0.2% chlorhexidine in the management of periodontal diseases: A randomized controlled clinical trial},
journal = {Journal of Indian Society of Periodontology},
year = {2026},
volume = {30},
number = {3},
pages = {392--400},
doi = {10.4103/jisp.jisp_80_25}
}
EUVIMED